By G HossainPosted on April 23, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The takeover will give Amneal control of four facilities to manufacture biosimilars for a planned wave of launches in the coming years. Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership Post navigation BBOT shakes up leadership as RAS competitors get more visibilityPwC pays $166M to settle HK Evergrande audit probe